Understanding Clinical Trial Participation in Metastatic Prostate Cancer
This study is looking at why some men with metastatic prostate cancer (cancer that has spread to other parts of the body) join clinical trials and why some finish them, while others don't. It's an observational study, meaning it won't test new treatments but will gather information from 500 men. The goal is to understand what factors, including your background, might make it easier or harder to participate in or complete a trial. This information could help improve future trials for patients like you. You can join if you are at least 18 years old and have metastatic prostate cancer.
- Study design
- This is an observational study planning to include 500 participants. It is not testing a specific intervention or drug.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will look at participation decisions at 3 months and completion rates at 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of patients who decide to participate in a metastatic prostate cancer clinical research3 months
- Rate of patients who remain in metastatic prostate cancer clinical research to trial completion12 months